(SGRY) Surgery Partners, Inc. SWOT Analysis Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(SGRY) Surgery Partners, Inc. Complete Analysis Pack
Your Credibility Toolkit Starts Here
This Surgery Partners, Inc. SWOT Analysis gives a concise, structured view of the company’s strengths, weaknesses, opportunities, and threats for research, strategy, or investment work; the page already includes a genuine preview of the report so you can evaluate style and substance before buying—purchase the full version to get the complete, ready-to-use analysis.
Strengths
126 facilities in 2021
Surgery Partners, Inc. operated 126 surgical facilities as of December 31, 2021, giving it a broad footprint across many local markets. That scale helps the company capture referrals from physicians and patients, while also improving purchasing and staffing efficiency. A larger network also supports stronger brand reach and steadier case flow.
31 states served
Surgery Partners, Inc. operates in 31 states, giving it a wide geographic base and lowering reliance on any single local market. That spread also helps it reach more physicians and patients while supporting stronger payer negotiations. A broader footprint can smooth volume swings when one region softens.
108 ambulatory surgery centers
Surgery Partners, Inc.'s 108 ambulatory surgery centers accounted for 108 of its 126 facilities, giving it a 86% outpatient-heavy mix. That scale supports lower-cost care and faster turnaround than inpatient settings. It also fits the ongoing shift toward non-inpatient procedures, where payors and patients both prefer shorter stays and lower total costs.
18 surgical hospitals
Surgery Partners, Inc. operated 18 surgical hospitals, giving it a deeper inpatient-capable platform than a pure ASC network. These hospitals can take on more complex cases, support higher-acuity surgeries, and keep care inside the same network, which can improve referral retention and scheduling flow. The hospital layer also broadens access for patients who need a higher level of surgical support.
- 18 surgical hospitals in the network
- Handles more complex cases than ASCs
- Strengthens referral and care depth
2 segments and 5 core specialties
Surgery Partners, Inc. is organized into two segments, Surgical Facility Services and Ancillary Services, which helps it serve patients across a broader care path. Its five core specialties—gastroenterology, general surgery, ophthalmology, orthopedics, and pain management—spread demand across different referral channels and procedure types. That mix lowers reliance on any single service line and supports steadier case volume.
- Two operating segments
- Five core specialties
- Broader patient mix
- Less service-line dependence
Surgery Partners’ Scale and Reach Power Its Growth
Surgery Partners, Inc. has a strong scale edge: 126 surgical facilities across 31 states, with 108 ambulatory surgery centers and 18 surgical hospitals. That mix gives it broad local reach, lower-cost outpatient capacity, and room for more complex cases. Its two segments and five core specialties also diversify case flow and reduce reliance on any one service line.
| Strength | Data |
|---|---|
| Facility scale | 126 sites |
| Geographic reach | 31 states |
| Outpatient mix | 108 ASCs |
What is included in the product
Detailed Word Document
Provides a clear SWOT framework for analyzing Surgery Partners, Inc.’s business strategy
Editable Excel File
Provides a fast, structured SWOT snapshot for Surgery Partners, Inc. to simplify strategic review and decision-making.
Reference Sources
Lists primary, reputable sources that back Surgery Partners' market, pricing, and competitive assumptions to speed due diligence and verify claims.
Weaknesses
Non-urgent procedure base
Surgery Partners, Inc.'s core business is non-urgent surgery, so volume can swing with consumer demand, physician referrals, and payer controls. That makes earnings more cyclical than emergency-based care; even a small shift in elective case mix can hit same-facility growth and margin. In 2025, this sensitivity stayed clear across outpatient surgery, where utilization is still tied to scheduling and payer approval, not urgent need.
108 ASCs vs 18 hospitals
Surgery Partners, Inc. runs 108 ambulatory surgery centers (ASCs) versus 18 hospitals, so its network is weighted toward lower-acuity outpatient care. That mix can cap higher-margin inpatient and complex-case revenue, especially when case volumes shift away from day surgery. It also leaves less room to capture adjacent services such as imaging, emergency, or post-acute care.
31-state footprint
Surgery Partners, Inc. operates in 31 states, so its reach still falls short of the full U.S. market of 50 states. That leaves clear gaps in several regions and can slow referral capture and network density. Expanding into new states needs capital, payer setup, and operating control, which can pressure margins before new sites scale.
5 specialty concentration
Surgery Partners, Inc. leans on five core specialties, so volume and pricing shifts in just a few service lines can hit results fast. In 2025, that kind of mix risk matters because reimbursement cuts or lower case counts in one specialty can ripple across the portfolio. A wider specialty base would spread that risk and reduce dependence on any one procedure set.
- Five-specialty concentration raises mix risk.
- Reimbursement changes can hit earnings faster.
- Lower utilization in one line matters more.
- Broader specialty spread would reduce exposure.
Surgery-linked ancillary revenue
Surgery Partners, Inc.’s ancillary revenue is still tightly linked to surgical volume: 5 add-on areas, including imaging, lab, pharmacy, therapy, and wound care, can soften fast if case flow slows. That makes the revenue mix more exposed to core procedure trends than pure service growth.
- 5 ancillary lines depend on surgeries
- Lower cases can hit add-ons fast
- Core volume drives most spillover revenue
Surgery Partners: Outpatient Exposure Drives Earnings Volatility
Surgery Partners, Inc. is exposed to elective-case swings, so 2025 earnings can move quickly with payer approvals, referrals, and patient timing. Its 108 ASCs and 18 hospitals skew the mix toward lower-acuity outpatient care, which can cap richer inpatient revenue. The 31-state footprint and five-specialty focus also leave it more exposed to regional and service-line shocks.
| Weakness | Latest data |
|---|---|
| Outpatient-heavy mix | 108 ASCs, 18 hospitals |
| Limited reach | 31 states |
| Concentration risk | 5 core specialties |
| Ancillary dependence | 5 add-on lines |
What You See Is What You Get
Surgery Partners, Inc. Reference Sources
This is the actual SWOT analysis document you’ll receive upon purchase—no surprises, just professional quality. The preview below is taken directly from the full SWOT report you'll get, and the complete, editable version becomes available after checkout. You’re viewing a live preview of the real file; buy now to unlock the entire detailed report.
Opportunities
19 unserved states
Surgery Partners, Inc. already operates in 31 states, leaving 19 states open for expansion. That gap gives it room to add new ambulatory surgery centers, patients, and physician referral sources without needing to fight for share in every existing market. With 2025 net revenue of $3.0 billion and 200+ facilities, even a few new state entries can widen its addressable patient base.
108 ASC outpatient shift
More procedures keep shifting from inpatient hospitals to lower-cost, shorter-stay ambulatory surgery centers, which fits Surgery Partners, Inc. well. With 108 ASCs in its network, the company is set to capture more same-day cases as payers and patients favor cheaper care settings. That mix can support volume growth and better operating leverage.
5 core specialties growth
Surgery Partners, Inc. can grow faster by adding orthopedic, ophthalmology, gastroenterology, general surgery, and pain management cases, since these are high-volume outpatient lines. In FY2025, revenue was about $3.1 billion, and higher case mix in these specialties can lift center utilization and margins. These services also drive repeat visits, which supports steadier demand.
2 segments cross-sell
Surgery Partners, Inc. has a clear cross-sell edge because its two-segment model links surgical facilities with ancillary services. That setup can move patients across more of the care episode, which supports higher capture per case and steadier volume for both sides of the business.
- Feed surgical demand into ancillary care
- Support repeat volume across segments
- Raise patient capture per episode
Ancillary service expansion
Surgery Partners, Inc. can lift revenue per patient by expanding imaging, pharmacy, lab, OB, oncology, PT, and wound care already inside its hospitals. The 2025-2026 upside is clear: each added service keeps more care in-house, supports stronger integrated care, and can raise margin per case if volumes stay high.
- More services, more revenue per patient
- Better care coordination and retention
- Higher in-house capture of referrals
Surgery Partners Has Room to Expand and Grow Outpatient Volume
Surgery Partners, Inc. can keep expanding into the 19 states it has not entered yet, while its 200+ facilities and 108 ASCs give it room to add volume in faster-growing outpatient markets.
Its 2025 net revenue of about $3.1 billion shows scale, and more orthopedic, GI, ophthalmology, and pain cases can lift utilization and margins.
The two-segment model also lets Surgery Partners, Inc. keep more care in-house, so ancillary services can raise revenue per patient.
| Opportunity | 2025/2026 data |
|---|---|
| State expansion | 31 of 50 states |
| Facility base | 200+ facilities, 108 ASCs |
| Scale | About $3.1B net revenue |
Threats
Reimbursement pressure
Reimbursement pressure is a real threat for Surgery Partners, Inc. because commercial insurers, Medicare, and Medicaid can change payment rules quickly. CMS’s 2025 Medicare Physician Fee Schedule cut the conversion factor by 2.83%, and tighter prior authorization from payers can delay cases and squeeze margins. Surgical providers are highly exposed because even small rate cuts can hit same-case economics fast.
Labor shortages
Nursing, anesthesia, and technical staff drive every case at Surgery Partners, Inc., so labor shortages can quickly slow volume. In 2025, tight staffing in these roles can force case delays, overtime, and higher contract labor pay, which lifts unit costs. That pressure can hit margins across the network and make operating results more volatile.
Health system competition
Surgery Partners, Inc. faces strong health system competition from hospital networks and other ASC operators, and it had about 200 facilities in 2025. Those rivals can pull physicians, win payor contracts, and take local volume, which can slow growth. That pressure can also force lower pricing and squeeze margins, especially in markets where a few systems control most referrals.
Regulation and compliance risk
Regulation and compliance risk is material for Surgery Partners because ambulatory surgery centers are monitored on billing, licensing, quality, and patient safety. Any change in CMS or state rules can raise audit, staffing, and documentation costs, and can slow new center openings. Compliance failures can also trigger fines, payer pressure, and reputational damage that can hit volume and margins.
- Billing scrutiny can raise costs.
- Rule changes can delay expansion.
- Safety lapses can hurt reputation.
Elective volume volatility
Surgery Partners, Inc. faces elective volume volatility because much of its mix comes from non-urgent procedures. When the economy weakens, public health disruptions hit, or patients face higher out-of-pocket costs, case volume can drop fast and push earnings down with it.
- Heavy elective-case exposure
- Demand falls in weak economies
- Shocks delay non-urgent surgery
- Lower volume can swing earnings
Surgery Partners Faces Fee Cuts, Labor Pressure, and Volume Risk
Surgery Partners, Inc. faces payer pressure, labor inflation, and heavy elective-case risk. In 2025, CMS cut the Medicare Physician Fee Schedule conversion factor by 2.83%, while its scale of about 200 facilities still leaves it exposed to local competition and reimbursement shocks. Any volume dip can hit margins fast.
| Threat | 2025 data |
|---|---|
| CMS fee pressure | -2.83% |
| Facility footprint | ~200 sites |
| Case mix risk | Mostly elective |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.